Tuesday, September 10, 2013 7:27:48 AM
Three unrelated thoughts:
First: I believe INO trades on the Frankfurt exchange, and that is why some are trading before regular hours.
Second: I really hope that Cowen exercised and sold their options yesterday. Odds are slim that that is what happened, but announcing the next morning would sort of be payback for the hedgies dumping shares all at once after a pipe which has happened a couple times now.
Third: Remember this is just two indications out of *many* that INO is working on. I am not in a position to comment intelligently on how the numbers of the deal compare to other similar deals, but *if* they turn out to be on the low side, I am very much o.k. with that for a first deal that bolsters INO's profile and puts pressure on companies to step up quickly if they have their eyes on other elements of the pipeline.
First: I believe INO trades on the Frankfurt exchange, and that is why some are trading before regular hours.
Second: I really hope that Cowen exercised and sold their options yesterday. Odds are slim that that is what happened, but announcing the next morning would sort of be payback for the hedgies dumping shares all at once after a pipe which has happened a couple times now.
Third: Remember this is just two indications out of *many* that INO is working on. I am not in a position to comment intelligently on how the numbers of the deal compare to other similar deals, but *if* they turn out to be on the low side, I am very much o.k. with that for a first deal that bolsters INO's profile and puts pressure on companies to step up quickly if they have their eyes on other elements of the pipeline.
Recent INO News
- INOVIO to Participate in Upcoming Scientific and Investor Conferences • PR Newswire (US) • 05/28/2026 12:05:00 PM
- Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China • PR Newswire (US) • 05/21/2026 08:05:00 PM
- INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights • PR Newswire (US) • 05/13/2026 08:05:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 05/08/2026 12:05:00 PM
- INOVIO to Report First Quarter Financial Results on May 13, 2026 • PR Newswire (US) • 05/01/2026 08:05:00 PM
- INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 04/06/2026 07:46:00 AM
- INOVIO Announces Pricing of $17.5 Million Public Offering • PR Newswire (US) • 04/02/2026 12:55:00 PM
- INOVIO Announces Proposed Public Offering • PR Newswire (US) • 04/02/2026 12:05:00 AM
- INOVIO to Participate in Upcoming Scientific Conference • PR Newswire (US) • 04/01/2026 02:29:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 03/30/2026 07:47:00 AM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/17/2026 01:00:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/12/2026 08:05:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/10/2026 01:00:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 03/09/2026 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:55:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:54:42 PM
- INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • PR Newswire (US) • 03/05/2026 09:05:00 PM
- INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) • PR Newswire (US) • 03/04/2026 01:05:00 PM
- Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:48:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:50 PM
